Related references
Note: Only part of the references are listed.Insights into resistance mechanism of hepatitis C virus nonstructural 3/4A protease mutant to boceprevir using umbrella sampling simulation study
Esmaeil Behmard et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir
Jennifer Timm et al.
ACS CHEMICAL BIOLOGY (2020)
Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®
James G. Taylor et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors
Aysegul Ozen et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation
Jirayu Kammarabutr et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Hepatitis C - New drugs and treatment prospects
Marianna Zajac et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection
Federico J. Mensa et al.
FUTURE MICROBIOLOGY (2019)
Understanding of the drug resistance mechanism of hepatitis C virus NS3/4A to paritaprevir due to D168N/Y mutations: A molecular dynamics simulation perspective
Thitiya Boonma et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches
Ahmed A. Ezat et al.
LIFE SCIENCES (2019)
Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach
Navaneethan Palanisamy et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2018)
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018
Maria C. Sorbo et al.
DRUG RESISTANCE UPDATES (2018)
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants
Linah N. Rusere et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Assessing the Performance of MM/PBSA, MM/GBSA, and QM-MM/GBSA Approaches on Protein/Carbohydrate Complexes: Effect of Implicit Solvent Models, QM Methods, and Entropic Contributions
Sushil K. Mishra et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease
Ashley N. Matthew et al.
STRUCTURE (2018)
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
Teresa I. Ng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics
Bodee Nutho et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2017)
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Paul Y. Kwo et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants
Ashley N. Matthew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection A Systematic Review
Oluwaseun Falade-Nwulia et al.
ANNALS OF INTERNAL MEDICINE (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172
Djade I. Soumana et al.
ACS CHEMICAL BIOLOGY (2016)
Hepatitis C virus NS3/4a protease inhibitors
John A. McCauley et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease
Djade I. Soumana et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir
Arthitaya Meeprasert et al.
MOLECULAR BIOSYSTEMS (2016)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450
Tami Pilot-Matias et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Molecular dynamics study on drug resistance mechanism of HCV NS3/4A protease inhibitor: BI201335
Jianjian Fu et al.
MOLECULAR SIMULATION (2015)
Binding mode and free energy prediction of fisetin/β-cyclodextrin inclusion complexes
Bodee Nutho et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2014)
Treatment of HCV infection with the novel NS3/4A protease inhibitors
Andrea De Luca et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis
Weiwei Xue et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Key Binding and Susceptibility of NS3/4A Serine Protease Inhibitors against Hepatitis C Virus
Arthitaya Meeprasert et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease
Yutong Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Molecular Docking Investigation of the Binding Interactions of Macrocyclic Inhibitors with HCV NS3 Protease and its Mutants (R155K, D168A and A156V)
Ahmed A. Ezat et al.
PROTEIN JOURNAL (2014)
Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435
Weiwei Xue et al.
ANTIVIRAL RESEARCH (2012)
Understanding the drug resistance mechanism of hepatitis C virus NS3/4A to ITMN-191 due to R155K, A156V, D168A/E mutations: A computational study
Dabo Pan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
Bill R. Miller et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
UCSF Chimera, MODELLER, and IMP: An integrated modeling system
Zheng Yang et al.
JOURNAL OF STRUCTURAL BIOLOGY (2012)
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Keith P. Romano et al.
PLOS PATHOGENS (2012)
Hepatitis C virus resistance to protease inhibitors
Philippe Halfon et al.
JOURNAL OF HEPATOLOGY (2011)
Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target
Maxwell D. Cummings et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
Keith P. Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system
Yupeng He et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The SCC-DFTB method and its application to biological systems
M. Elstner
THEORETICAL CHEMISTRY ACCOUNTS (2006)
Potential energy functions for atomic-level simulations of water and organic and biomolecular systems
WL Jorgensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus
V Frecer et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)
Exploring protein native states and large-scale conformational changes with a modified generalized born model
A Onufriev et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
Share Paper
